These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30896149)

  • 21. Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators.
    Luo Y; Cheng J; Hu Z; Ban H; Wu S; Hwang N; Kulp J; Li Y; Du Y; Chang J; Viswanathan U; Guo JT
    Antiviral Res; 2021 Jul; 191():105080. PubMed ID: 33933516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cetylpyridinium chloride interaction with the hepatitis B virus core protein inhibits capsid assembly.
    Seo HW; Seo JP; Cho Y; Ko E; Kim YJ; Jung G
    Virus Res; 2019 Apr; 263():102-111. PubMed ID: 30639191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus.
    Berke JM; Dehertogh P; Vergauwen K; Van Damme E; Mostmans W; Vandyck K; Pauwels F
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of small synthetic molecules targeting HBV capsid assembly.
    Liu N; Zhao F; Zhan P; Liu X
    Med Chem; 2015; 11(8):710-6. PubMed ID: 25985859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy.
    Kim H; Ko C; Lee JY; Kim M
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
    Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
    ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways.
    Guo F; Zhao Q; Sheraz M; Cheng J; Qi Y; Su Q; Cuconati A; Wei L; Du Y; Li W; Chang J; Guo JT
    PLoS Pathog; 2017 Sep; 13(9):e1006658. PubMed ID: 28945802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion Formation.
    Orabi A; Bieringer M; Geerlof A; Bruss V
    J Virol; 2015 Sep; 89(18):9281-7. PubMed ID: 26136564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PGC1α Transcriptional Adaptor Function Governs Hepatitis B Virus Replication by Controlling HBcAg/p21 Protein-Mediated Capsid Formation.
    Shalaby RE; Iram S; Çakal B; Oropeza CE; McLachlan A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The premise of capsid assembly modulators towards eliminating HBV persistence.
    Bassit L; Amblard F; Patel D; Biteau N; Chen Z; Kasthuri M; Zhou S; Schinazi RF
    Expert Opin Drug Discov; 2023; 18(9):1031-1041. PubMed ID: 37477111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-Free Hepatitis B Virions.
    Ning X; Luckenbaugh L; Liu K; Bruss V; Sureau C; Hu J
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future anti-HBV strategies.
    Gane EJ
    Liver Int; 2017 Jan; 37 Suppl 1():40-44. PubMed ID: 28052637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus: new therapeutic perspectives.
    Lin CL; Yang HC; Kao JH
    Liver Int; 2016 Jan; 36 Suppl 1():85-92. PubMed ID: 26725903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches.
    Senaweera S; Du H; Zhang H; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New antivirals for the treatment of chronic hepatitis B.
    Soriano V; Barreiro P; Benitez L; Peña JM; de Mendoza C
    Expert Opin Investig Drugs; 2017 Jul; 26(7):843-851. PubMed ID: 28521532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores.
    Huber AD; Pineda DL; Liu D; Boschert KN; Gres AT; Wolf JJ; Coonrod EM; Tang J; Laughlin TG; Yang Q; Puray-Chavez MN; Ji J; Singh K; Kirby KA; Wang Z; Sarafianos SG
    ACS Infect Dis; 2019 May; 5(5):750-758. PubMed ID: 30582687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based Design of Novel Hepatitis B Virus Capsid Assembly Modulators.
    Detta E; Corcuera A; Urban A; Goldner T; Bonsmann S; Engel F; May MM; Buschmann H; Fianchini M; Alza E; Pericàs MA; Pushkarev PA; Varenyk AO; Yakovyuk TY; Homon AA; Sokoliuk PA; Smaliy R; Donald A
    Bioorg Med Chem Lett; 2023 Sep; 93():129412. PubMed ID: 37499987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor.
    Kim SY; Kim H; Kim SW; Lee NR; Yi CM; Heo J; Kim BJ; Kim NJ; Inn KS
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.